Book a Meeting
Creative Biolabs - ADCC+ Antibody

Anti-CD30 Antibody, Non-Fucosylated (BioBet-1748ZP) (CAT#: BioBet-1748ZP) Datasheet

Target
CD30
Isotype
IgG
Description
Non-Fucosylated Anti-Human CD30 (5F11) is a glycosylation-modified therapeutic biobetter antibody.
Antibody Indication
Hodgkin lymphoma, systemic anaplastic large cell lymphoma
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CD30 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
TNFRSF8
Full Name
TNFRSF8
Alternative Names
TNF Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30;
Gene ID
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
5F11
Host
Murine
Species Reactivity
Human
Description
Defuc-5F11 showed from 1.61 times (for L540 cells) to 3.25 times (for L1236 cells) higher percentage of lysis.
Antibody Indication
Hodgkin lymphoma, systemic anaplastic large cell lymphoma

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.